Cargando…
TIM3, a human acute myeloid leukemia stem cell marker, does not enrich for leukemia-initiating stem cells in B-cell acute lymphoblastic leukemia
Autores principales: | Bueno, Clara, Martínez, Alba, Romecin, Paola Alejandra, Zanetti, Samanta Romina, Tirtakusuma, Ricky, Genesca, Eulalia, Camós, Mireia, Ramírez-Orellana, Manuel, Anguita, Eduardo, Ballerini, Paola, Locatelli, Franco, Fuster, José Luis, Menéndez, Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388286/ https://www.ncbi.nlm.nih.gov/pubmed/36655434 http://dx.doi.org/10.3324/haematol.2022.282394 |
Ejemplares similares
-
The role of stem cell transplantation in the management of Philadelphia chromosome-positive acute lymphoblastic leukemia
por: Ribera, Jose-Maria, et al.
Publicado: (2018) -
Latest Contributions of Genomics to T-Cell Acute Lymphoblastic Leukemia (T-ALL)
por: Genescà, Eulàlia, et al.
Publicado: (2022) -
Bispecific T-cell engaging antibodies in B-cell precursor acute lymphoblastic leukemias: focus on blinatumomab
por: Ribera, Jose-Maria, et al.
Publicado: (2020) -
Treatment of Adolescent and Young Adults with Acute Lymphoblastic Leukemia
por: Ribera, Josep-Maria, et al.
Publicado: (2014) -
Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
por: Barbosa, Karina, et al.
Publicado: (2023)